Fingerprint
Dive into the research topics of 'Complement dependent cytotoxicity in chronic lymphocytic leukemia: Ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically